RecruitingNCT01793168
Neuromuscular
Hereditary inclusion body myopathy type 4
1
studies recruiting now
as of 7 Sept 2026
1
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
15 Feb 2013
most recent study posted
among recruiting studies
Recruiting trials
Showing the 1 most recently updated recruiting study, as recorded 7 Sept 2026. Live status on each study page.
Search all Hereditary inclusion body myopathy type 4 studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Hereditary inclusion body myopathy type 4 study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Hereditary inclusion body myopathy type 4
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
12 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Bimagrumab
Phase 3Sirolimus (Fyarro)
Phase 3Arimoclomol
Phase 2/3Ulviprubart
Phase 2Garetosmab
Phase 2Alemtuzumab (Campath mabcampath)
Phase 2Trevogrumab
Phase 2Ruxolitinib (Jakavi)
+ 4 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).